Assignee
BAYER PHARMACEUTICALS CORP
US·68 granted patents·46 pending applications·1,143 citations·filing 1994–2014
Top patents by PatentIndex Score
114 records- 0197US7235576B1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jun 26, 2007·94 cites·47 claims
- 0296US7528255B2Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 5, 2009·35 cites·15 claims
- 0396US7351834B1ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Apr 1, 2008·64 cites·41 claims
- 0494US7329670B1Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Feb 12, 2008·76 cites·7 claims
- 0594US7041646B2Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonistsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted May 9, 2006·43 cites·3 claims
- 0694US6955807B1IL-2 selective agonists and antagonistsBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Oct 18, 2005·140 cites·10 claims
- 0794US6784157B2Peptides and peptidomimetics with structural similarity to human p53 that activate p53 functionBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·31 cites·6 claims
- 0892US6864069B2Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Mar 8, 2005·34 cites·3 claims
- 0992US6689353B1Stabilized interleukin 2BAYER PHARMACEUTICALS CORP·Filed 2000·Granted Feb 10, 2004·73 cites·6 claims
- 1091US7371763B2Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER PHARMACEUTICALS CORP·Filed 2005·Granted May 13, 2008·17 cites·37 claims
- 1191US6689582B1Polynucleotide molecules encoding proteins having proteinase inhibitor activityBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Feb 10, 2004·39 cites·6 claims
- 1290US7244616B2Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cellsBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Jul 17, 2007·15 cites·7 claims
- 1388US7563791B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Jul 21, 2009·14 cites·8 claims
- 1488US6972319B1Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Dec 6, 2005·17 cites·5 claims
- 1587US6960601B2Preparation and use of imidazole derivatives for treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Nov 1, 2005·26 cites·8 claims
- 1687US6849638B24-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditionsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Feb 1, 2005·36 cites·12 claims
- 1786US7517880B2Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Apr 14, 2009·25 cites·21 claims
- 1886US7511048B2PyrimidothienoindazolesBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Mar 31, 2009·4 cites·10 claims
- 1986US7091228B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Aug 15, 2006·18 cites·20 claims
- 2086US6943172B2Rho-kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Sep 13, 2005·20 cites·5 claims
- 2186US6903101B1Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activityBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Jun 7, 2005·21 cites·22 claims
- 2286US6784167B217-beta-hydroxysteroid dehydrogenase-II inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·35 cites·17 claims
- 2386US6689883B1Substituted pyridines and pyridazines with angiogenesis inhibiting activityBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Feb 10, 2004·20 cites·6 claims
- 2486US6660752B22,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·24 cites·30 claims
- 2585US7098207B2Imidazotriazinones and the use thereofBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Aug 29, 2006·7 cites·5 claims
- 2685US6900205B21,8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 31, 2005·19 cites·36 claims
- 2783US7358386B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Apr 15, 2008·5 cites·2 claims
- 2883US6911449B2Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acidsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jun 28, 2005·7 cites·4 claims
- 2982US6828335B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 7, 2004·15 cites·102 claims
- 3081US7511041B2Fused azole-pyrimidine derivativesBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Mar 31, 2009·22 cites·12 claims
- 3180US7585888B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2008·Granted Sep 8, 2009·4 cites·5 claims
- 3280US6930114B2Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 16, 2005·19 cites·8 claims
- 3380US6924290B2Rho-kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Aug 2, 2005·14 cites·17 claims
- 3479US8772027B2Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cellsBAYER PHARMACEUTICALS CORP·Filed 2013·Granted Jul 8, 2014·1 cites·8 claims
- 3578US8765466B2Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cellsBAYER PHARMACEUTICALS CORP·Filed 2013·Granted Jul 1, 2014·1 cites·4 claims
- 3678US7951588B2Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cellsBAYER PHARMACEUTICALS CORP·Filed 2007·Granted May 31, 2011·1 cites·4 claims
- 3776US7112597B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 26, 2006·7 cites·73 claims
- 3876US7109196B21,8 Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 19, 2006·7 cites·20 claims
- 3975US6994956B2Method for assaying enzyme activityBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Feb 7, 2006·13 cites·24 claims
- 4074US7423156B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Sep 9, 2008·1 cites·20 claims
- 4174US6670175B2Cryopreservation bag assembly for mammalian cell linesBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 30, 2003·44 cites·6 claims
- 4272US6699860B2Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Mar 2, 2004·8 cites·20 claims
- 4371US6762184B2Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acidsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Jul 13, 2004·1 cites·4 claims
- 4470US9284591B2Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cellsBAYER PHARMACEUTICALS CORP·Filed 2014·Granted Mar 15, 2016·0 cites·12 claims
- 4570US7582645B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 1, 2009·4 cites·10 claims
- 4670US7144885B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Dec 5, 2006·4 cites·26 claims
- 4769US7803956B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Granted Sep 28, 2010·0 cites·19 claims
- 4867US7351735B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Apr 1, 2008·3 cites·21 claims
- 4967US6780859B2Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Aug 24, 2004·3 cites·16 claims
- 5067US2010075967A1Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
Showing the top 50 of 114 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →